Cargando…
SARS-CoV-2-associated critical ill myopathy or pure toxic myopathy?
Autores principales: | Finsterer, Josef, Scorza, Fulvio A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836331/ https://www.ncbi.nlm.nih.gov/pubmed/33002612 http://dx.doi.org/10.1016/j.ijid.2020.09.1463 |
Ejemplares similares
-
Does SARS-CoV-2 truly cause infectious myopathy?
por: Finsterer, Josef, et al.
Publicado: (2021) -
Exclude differentials before attributing post-COVID fatigue to myopathy
por: Finsterer, Josef, et al.
Publicado: (2021) -
SARS-CoV-2 may unravel metabolic myopathy mistaken for myasthenia
por: Finsterer, Josef, et al.
Publicado: (2021) -
Impact of SARS-CoV-2 vaccines on the nervous system
por: Scorza, Fulvio Alexandre, et al.
Publicado: (2022) -
Pathophysiology of SARS-CoV-2 associated ischemic stroke
por: Finsterer, Josef, et al.
Publicado: (2022)